Daniel R. Glickman is Director at CME GROUP INC. (CME). They have made 7 open-market trades across 1 company since 2017, most recently 2024-06-25.
CIK 0001212819
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CME | SELL | 2024-06-06 | 2024-06-07 | $201.44 | $131K | -0.2% | -2.0% | +10.3% |
| CME | SELL | 2023-08-09 | 2023-08-09 | $206.09 | $309K | -1.9% | -0.8% | +2.8% |
| CME | SELL | 2022-08-31 | 2022-08-31 | $196.39 | $98K | -0.2% | -8.9% | -10.1% |
| CME | SELL | 2022-03-01 | 2022-03-02 | $234.30 | $176K | -3.7% | +0.6% | -16.6% |
| CME | SELL | 2020-08-17 | 2020-08-19 | $173.22 | $156K | +2.8% | -1.1% | -1.7% |
| CME | SELL | 2019-08-28 | 2019-08-28 | $216.01 | $108K | -5.3% | -1.4% | -5.1% |
| CME | SELL | 2017-08-28 | 2017-08-29 | $126.65 | $215K | +1.9% | +7.5% | +12.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.